4/A: scPharmaceuticals CFO Rachael Nokes Corrects Stock Transaction Price in Amended SEC Filing
SEC Filing
Rachael Nokes, CFO and Treasurer of scPharmaceuticals Inc., amended a Form 4 filing to correct the price of securities acquired on August 6, 2024.
Summary
- Rachael Nokes, CFO and Treasurer of scPharmaceuticals Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the price of common stock acquired on August 6, 2024.
- The corrected price is $1.66 per share, as opposed to the originally reported $0.
- The transaction involved the acquisition of 10,445 shares.
- Following the reported transaction, Nokes beneficially owns 72,851 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate positive or negative sentiment.
Industry Context
This is a routine disclosure related to insider trading and beneficial ownership, required by the SEC to ensure transparency and prevent insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/06/2024 | Date of the stock transaction (acquisition of shares). |
| 08/08/2024 | Date of original filing (amended on 08/28/2024). |
| 08/28/2024 | Date of the amended filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.